349 related articles for article (PubMed ID: 6831390)
1. On the formation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone during smoking.
Adams JD; Lee SJ; Vinchkoski N; Castonguay A; Hoffmann D
Cancer Lett; 1983 Jan; 17(3):339-46. PubMed ID: 6831390
[TBL] [Abstract][Full Text] [Related]
2. Tobacco-specific nitrosamines in commercial cigarettes: possibilities for reducing exposure.
Fischer S; Spiegelhalder B; Preussmann R
IARC Sci Publ; 1991; (105):489-92. PubMed ID: 1855903
[TBL] [Abstract][Full Text] [Related]
3. Investigations on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes.
Fischer S; Spiegelhalder B; Eisenbarth J; Preussmann R
Carcinogenesis; 1990 May; 11(5):723-30. PubMed ID: 2335004
[TBL] [Abstract][Full Text] [Related]
4. Tobacco-specific nitrosamines in Canadian cigarettes.
Fischer S; Castonguay A; Kaiserman M; Spiegelhalder B; Preussmann R
J Cancer Res Clin Oncol; 1990; 116(6):563-8. PubMed ID: 2254375
[TBL] [Abstract][Full Text] [Related]
5. Tobacco-Specific Nitrosamines in the Tobacco and Mainstream Smoke of U.S. Commercial Cigarettes.
Edwards SH; Rossiter LM; Taylor KM; Holman MR; Zhang L; Ding YS; Watson CH
Chem Res Toxicol; 2017 Feb; 30(2):540-551. PubMed ID: 28001416
[TBL] [Abstract][Full Text] [Related]
6. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
[TBL] [Abstract][Full Text] [Related]
7. Tobacco-specific nitrosamines in European and USA cigarettes.
Fischer S; Spiegelhalder B; Preussmann R
Arch Geschwulstforsch; 1990; 60(3):169-77. PubMed ID: 2369279
[TBL] [Abstract][Full Text] [Related]
8. Thirdhand cigarette smoke in an experimental chamber: evidence of surface deposition of nicotine, nitrosamines and polycyclic aromatic hydrocarbons and de novo formation of NNK.
Schick SF; Farraro KF; Perrino C; Sleiman M; van de Vossenberg G; Trinh MP; Hammond SK; Jenkins BM; Balmes J
Tob Control; 2014 Mar; 23(2):152-9. PubMed ID: 23716171
[TBL] [Abstract][Full Text] [Related]
9. A Model To Estimate the Sources of Tobacco-Specific Nitrosamines in Cigarette Smoke.
Lipowicz PJ; Seeman JI
Chem Res Toxicol; 2017 Aug; 30(8):1556-1561. PubMed ID: 28651431
[TBL] [Abstract][Full Text] [Related]
10. Tobacco-specific N-nitrosamines NNN and NNK levels in cigarette brands between 2000 and 2014.
Gunduz I; Kondylis A; Jaccard G; Renaud JM; Hofer R; Ruffieux L; Gadani F
Regul Toxicol Pharmacol; 2016 Apr; 76():113-20. PubMed ID: 26806560
[TBL] [Abstract][Full Text] [Related]
11. Assessment of major carcinogenic tobacco-specific N-nitrosamines in Thai cigarettes.
Brunnemann KD; Mitacek EJ; Liu Y; Limsila T; Suttajit M
Cancer Detect Prev; 1996; 20(2):114-21. PubMed ID: 8706036
[TBL] [Abstract][Full Text] [Related]
12. Levels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties.
Ding YS; Zhang L; Jain RB; Jain N; Wang RY; Ashley DL; Watson CH
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3366-71. PubMed ID: 19064552
[TBL] [Abstract][Full Text] [Related]
13. Reductions in the tobacco specific nitrosamine (TSNA) content of tobaccos taken from commercial Canadian cigarettes and corresponding reductions in TSNA deliveries in mainstream smoke from such cigarettes.
Rickert WS; Joza PJ; Sharifi M; Wu J; Lauterbach JH
Regul Toxicol Pharmacol; 2008 Aug; 51(3):306-10. PubMed ID: 18508168
[TBL] [Abstract][Full Text] [Related]
14. Trends Over Time in Tobacco-Specific Nitrosamines (TSNAs) in Whole Tobacco and Smoke Emissions From Cigarettes Sold in Canada.
Czoli CD; Hammond D
Nicotine Tob Res; 2018 Apr; 20(5):649-653. PubMed ID: 28595283
[TBL] [Abstract][Full Text] [Related]
15. Tobacco Nitrate and Free Radical Levels in the Mainstream Smoke of US Cigarette Brands.
Mocniak LE; Trushin N; Bitzer ZT; Prabhu P; Richie JP
Chem Res Toxicol; 2023 Apr; 36(4):653-659. PubMed ID: 36930521
[TBL] [Abstract][Full Text] [Related]
16. Formation and analysis of tobacco-specific N-nitrosamines.
Brunnemann KD; Prokopczyk B; Djordjevic MV; Hoffmann D
Crit Rev Toxicol; 1996; 26(2):121-37. PubMed ID: 8688156
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry.
Stepanov I; Knezevich A; Zhang L; Watson CH; Hatsukami DK; Hecht SS
Tob Control; 2012 Jan; 21(1):44-8. PubMed ID: 21602537
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in sidestream cigarette smoke increase after release into indoor air: results from unpublished tobacco industry research.
Schick SF; Glantz S
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1547-53. PubMed ID: 17684127
[TBL] [Abstract][Full Text] [Related]
19. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
Kavvadias D; Scherer G; Cheung F; Errington G; Shepperd J; McEwan M
Biomarkers; 2009 Dec; 14(8):547-53. PubMed ID: 19747086
[TBL] [Abstract][Full Text] [Related]
20. Thirdhand Smoke at Philip Morris.
Whitlatch A; Schick S
Nicotine Tob Res; 2019 Nov; 21(12):1680-1688. PubMed ID: 30053240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
